New Additions

New
CHLORHEXIDINE GLUCONATE ORAL RINSE, USP 0.12%
New
Glycerol Phenylbutyrate Oral Liquid
New
10% Calcium Chloride Injection, USP
New
VITAMIN D SUPPLEMENT DROPS
New
PROPRANOLOL HYDROCHLORIDE ORAL SOLUTION
New
PrednisoLONE SODIUM PHOSPHATE ORAL SOLUTION (5 mg)
New
ONDANSETRON ORAL SOLUTION, USP Unit Dose
New
PENTAMIDINE ISETHIONATE INHALATION SOLUTION
New
PENTAMIDINE ISETHIONATE INJECTION
New
CHILDREN’S SIMETHICONE DROPS
New
INFANTS’ SIMETHICONE DROPS
New
CHILDREN’S MULTIVITAMIN (WITH IRON)
New
CHILDREN’S MULTIVITAMIN (NO IRON)
New
VORICONAZOLE INJECTION 200 mg per 20 mL
New
VANCOMYCIN HYDROCHLORIDE CAPSULES, USP 250 mg
New
VANCOMYCIN HYDROCHLORIDE CAPSULES, USP 125 mg
New
ONDANSETRON ORAL SOLUTION, USP
New
LITHIUM ORAL SOLUTION, USP
New
LITHIUM ORAL SOLUTION, USP
New
BENZOCAINE 20% SOLUTION 0.5 mL Single-Unit Dose Applicators
New
MUPIROCIN OINTMENT USP, 2%
New
Brivaracetam Oral Solution CV
New
Brivaracetam Injection CV

Our Products

With over 250 product NDCs, PAI Pharma offers the broadest portfolio of unit-dose and liquid medicines. Our products are manufactured in an FDA CGMP-compliant facility and supported by a rigorous quality control process.

Explore Our Portfolio

Nutritional Health and Balance Products for Infants and Children

PAI Pharma is expanding our portfolio to include nutrient supplements and medicines for infants and children. These new products include Multivitamin Supplements (with and without iron), Infant and Children Simethicone Drops, and Vitamin D Supplement Drops are coming soon! All products are provided in pre-filled oral syringes for easy dosing.

Learn More

Latest News

Press Release

PAI Pharma Acquires Nexus Pharmaceuticals, Expanding Portfolio of Sterile Injectable Products

PAI Pharma Acquires Nexus Pharmaceuticals Read More

11/13/2026
Press Release

PAI Pharma Acquires Nivagen Pharmaceuticals, Expanding Domestic Sterile Injectable Manufacturing and Ready-To-Use Product Offering in the Hospital Market

PAI Pharma Acquires Nivagen Pharmaceuticals Read More

01/06/2026
Press Release

Private Equity Firm Olympus Partners Acquires Liquid Generic Leader PAI Pharma

Olympus Partners has acquired PAI Pharma Read More

02/13/2025
View All

Join our Team

As a patient-focused company, our employees are the one that help us make a real difference. Our team is continuously evolving and growing, with opportunities in research and development, sales, marketing, finance, human resources, manufacturing, and technology.

View Openings